ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 310 out of 1107

$1.04M Total Retail Price of All Prescriptions

Rank: 86 out of 1107

454 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,305 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LEVOTHYROXINE SODIUM 437 377 1 3
PRAVASTATIN SODIUM 379 300 2 12
SERTRALINE HCL 260 235 3 20
OMEPRAZOLE 253 203 4 4
FUROSEMIDE 251 195 5 7
AMLODIPINE BESYLATE 239 199 6 6
HYDROCODONE-ACETAMINOPHEN 212 168 S3 7 1
LISINOPRIL 206 161 8 2
HYDROCHLOROTHIAZIDE 199 172 9 11
POTASSIUM CHLORIDE 172 145 10 14
GABAPENTIN 164 122 11 9
ATORVASTATIN CALCIUM 159 137 12 13
METFORMIN HCL 157 114 13 8
METOPROLOL TARTRATE 155 113 14 10
FLUTICASONE PROPIONATE 150 94 15 38
NEXIUM 142 105 16 18
ALENDRONATE SODIUM 135 109 17 41
MELOXICAM 116 84 18 25
AZITHROMYCIN 115 80 19 35
BYSTOLIC 105 89 20 138
DIOVAN 102 86 21 51
HYDRALAZINE HCL 102 94 21 99
CLOPIDOGREL 100 90 23 28
SYNTHROID 99 72 24 70
CRESTOR 98 85 25 23
WARFARIN SODIUM 98 87 25 15
TRAMADOL HCL 98 59 25 26
LEVOFLOXACIN 92 81 28 71
PLAVIX 86 77 29 39
CARVEDILOL 85 75 30 27
SINGULAIR 81 59 31 65
JANUVIA 80 55 32 60
DONEPEZIL HCL 80 80 32 32
METOPROLOL SUCCINATE 75 64 34 16
GLIPIZIDE ER 67 61 35 115
METHYLPREDNISOLONE 66 44 36 119
LOSARTAN POTASSIUM 66 53 36 29
CYMBALTA 65 35 38 50
CYANOCOBALAMIN INJECTION 65 63 38 422
DIOVAN HCT 63 49 40 106
PROAIR HFA 63 40 40 37
KLOR-CON M10 61 46 42 159
GLIMEPIRIDE 60 52 43 43
ALPRAZOLAM 59 53 44 87
ROPINIROLE HCL 57 46 45 69
LEVOCETIRIZINE DIHYDROCHLORIDE 57 45 45 203
RANITIDINE HCL 55 43 47 21
TAMSULOSIN HCL 55 48 47 30
ALLOPURINOL 55 51 47 36
ATENOLOL 54 35 50 19
SIMVASTATIN 51 36 51 5
MECLIZINE HCL 50 40 52 114
NIASPAN 50 35 52 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 47 52 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.